8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Abbott filed Q4 & FY2025 results on Jan 22, 2026 (Exhibit 99.1).
Filed with the SEC on · Summarized by InvestorsBot
Abbott filed Q4 & FY2025 results on Jan 22, 2026 (Exhibit 99.1). The release emphasizes non‑GAAP "net earnings excluding specified items" to show underlying ops — management says useful but not a GAAP substitute. 📈 $ABT #earnings #healthcare
Non‑GAAP adjustments cited: acquisition & contingent‑consideration fair‑value, restructuring, legal reserves, regulatory costs, tax items (deferred benefit, prior‑year positions, excess stock‑comp benefits) and exclusion of intangible amortization. Check GAAP reconciliation. 🔍 $ABT #investing #healthcare